Results 151 to 160 of about 185,906 (291)

Clinical practice guideline for psoriasis management in Latin America. [PDF]

An Bras Dermatol
Valenzuela F, Castro Ayarza JR, Kaplan D, Londoño-García AM, Macías García KDR, Magariños G, Rivas Záldivar ES, Franco M, Cano S, Cortés C, Cárdenas PJ, Castro C, Ferreira R, Martínez S, Ibatá Bernal L, Castillo JC, Ospina J.   +16 more
europepmc   +1 more source

A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management

, 2019
: Objective Treat-to-target (T2T) is an algorithm to reach a predefined outcome. Here, we define a T2T outcome for moderate-to-severe psoriasis vulgaris.
Bonardeaux, Chantal, Hillary, T., Segaert, S., Lanssens, Sven, Temmerman, Linda, Henno, Audrey, Vandaele, Mark, Boonen, Hugo, Stockman, Annelies, Vermeersch, Karen, Grine, L., Ghislain, P. -D., Lambert, Julien, de la Brassinne, M., Nikkels F., Arjen, Willaert, F., Suys, Erwin, Benhadou, Farida   +17 more
core  

Startups Driving Artificial Intelligence Into Clinical Dermatology

JEADV Clinical Practice, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest, Benjamin Miguel Monteagudo, Stanislas Vandier, Mullarkey Dan, Svedenhag Per, Jon Friis, Monisha Madhumita, Lilit Garibyan, Tu‐Anh Duong, Merete Haedersdal, Vinzent Kevin Ortner   +10 more
wiley   +1 more source

Screening for Eating Disorders in Psoriasis Patients: A Multicenter Cross-Sectional Study. [PDF]

Psoriasis (Auckl)
Calabrese L, Musumeci ML, Ortega R, Bardazzi F, Sacchelli L, Megna M, Micali G.   +6 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonist therapy in patients with psoriasis and diabetes mellitus type 2.

reservedIntroduction: Psoriasis is a chronic inflammatory skin disease often associated with type 2 diabetes and other metabolic disorders. GLP-1 receptor agonists (GLP-1 RAs), used for glycemic control and weight management in diabetes, have shown ...
MIOSO, GUIDO
core  

Imiquimod-induced Psoriasis-like Mouse Model

, 2012
Psoriasis is a chronic inflammatory skin disease affecting 1-2% of the population. The pathogenesis of psoriasis is not fully understood, but recent progress in studying its complex mechanisms revealed that crosstalk among T cells, epidermal ...
이민걸
core  

Refractory Eczema as a Presenting Feature of Common Variable Immunodeficiency

JEADV Clinical Practice, EarlyView.
ABSTRACT Common variable immunodeficiency (CVID) is the most prevalent symptomatic inborn error of immunity (IEI) in adults. It presents with recurrent infections and non‐infectious complications, including autoimmunity, lymphoproliferation and dermatitis.
Mercedes Sanchez‐Diaz, Lars Matthies, Andrea Vanegas Ramirez   +2 more
wiley   +1 more source

The promise of oral IL-23 blockade: One-year control of high-impact site psoriasis. [PDF]

J Eur Acad Dermatol Venereol
Jendoubi F.
europepmc   +1 more source

DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain

JEADV Clinical Practice, EarlyView.
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau, Javier Ortiz de Frutos, Raquel Rivera‐Díaz, Lluís Puig, Jaume Notario Rosa, José Luis López‐Estebaranz, Vicente García‐Patos Briones, Ana Martín‐Santiago, José Ignacio Rojo‐Laguna, Elisabet Fernández‐Martínez, Lara Gómez‐Labrador, Esteban Daudén   +11 more
wiley   +1 more source

The Global Burden and Temporal Trends of Psoriasis, 1990-2021: Implications From the COVID-19 Pandemic. [PDF]

Health Sci Rep
Guo Y, Yang J, Xiao M, Zhang Z, Ma K, Fu X, Yang S.   +6 more
europepmc   +1 more source